Fulcrum Therapeutics, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
Rok finansowy 2017 2018 2018 2018 2018 2019 2019 2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024
Kwartał Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Data 2018-03-31 2018-06-30 2018-09-30 2018-12-31 2019-03-31 2019-06-30 2019-09-30 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30 2024-12-31 2025-03-31
Przychód (mln) 0 0 0 0 0 0 0 0 1 2 2 4 5 4 5 5 3 2 1 1 0 1 1 1 0 80 0 0 0
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% inf% inf% inf% inf% 538.5% 119.1% 167.0% 19.7% -45.88% -57.04% -76.03% -86.46% -88.62% -53.24% -35.84% 27.2% -100.00% 8990.9% -100.00% -100.00% 0.0%
Marża brutto 0.0% 0.0% 0.0% 0.0% -inf% -inf% -inf% -inf% -1830.93% -538.75% -704.17% -346.58% -241.07% -296.67% -246.04% 87.7% 79.3% -1229.38% 49.3% 13.7% -91.86% 31.8% 34.1% 41.7% -inf% 78.4% 0.0% 0.0% 0.0%
Koszty i Wydatki (mln) 7 8 9 9 37 13 17 16 20 18 21 22 22 24 26 29 29 36 25 29 28 28 28 29 30 28 25 19 0
EBIT (mln) -7 -8 -9 -9 -37 -13 -17 -16 -19 -16 -19 -18 -17 -20 -21 -24 -26 -34 -24 -28 -28 -27 -27 -28 -30 52 -25 -19 -20
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% 409.3% 71.9% 87.1% 78.3% -49.51% 18.0% 12.3% 7.9% -9.33% 23.6% 8.7% 32.5% 52.5% 73.9% 17.3% 18.7% 7.5% -20.28% 12.7% 0.1% 6.8% 292.3% -8.43% -30.59% -31.61%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -2506.13% -796.20% -1033.77% -420.99% -355.88% -449.26% -420.87% -465.78% -1003.01% -1819.08% -2058.75% -4083.65% -9471.19% -3101.36% -3615.28% -3213.78% 0.0% 65.6% 0.0% nan nan
Przychody fiansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Amortyzacja (mln) 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 0 0 0 0 0
EBITDA (mln) -7 -8 -9 -9 -37 -13 -16 -16 -18 -15 -19 -17 -16 -19 -20 -23 -25 -34 -23 -27 -27 -27 -27 -27 -29 56 -23 -19 -20
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -2434.27% -768.55% -1003.79% -420.99% -343.29% -433.92% -408.33% -465.78% -982.33% -1783.16% -1928.49% -4094.74% -9471.19% -3036.93% -3545.32% -3155.45% 0.0% 65.6% 0.0% nan nan
NOPLAT (mln) -7 -8 -9 -9 -37 -13 -17 -16 -18 -16 -19 -18 -17 -20 -21 -23 -26 -34 -24 -26 -25 -24 -24 -25 -27 55 -22 -17 -18
Podatek (mln) 0 0 -0 -0 -0 -0 -0 -1 0 0 0 -1 0 -0 0 -1 -0 -0 0 -3 -3 1 0 3 0 0 0 0 0
Zysk Netto (mln) -7 -8 -9 -9 -37 -13 -17 -16 -18 -16 -19 -18 -17 -20 -21 -23 -26 -34 -24 -24 -22 -24 -24 -25 -27 55 -22 -17 -18
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% 430.9% 67.8% 85.0% 82.0% -49.92% 19.1% 14.6% 9.9% -7.87% 25.3% 9.3% 32.5% 52.1% 73.4% 16.1% 0.6% -16.40% -30.19% -0.14% 4.8% 24.3% 333.0% -9.66% -33.07% -34.29%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -2460.27% -784.25% -1026.08% -419.41% -354.96% -448.48% -419.78% -464.29% -997.61% -1810.31% -2033.05% -3449.64% -7328.14% -2702.61% -3164.30% -2842.25% 0.0% 69.3% 0.0% nan nan
EPS -0.41 -0.46 -0.53 -0.52 -1.58 -0.56 -0.93 -0.71 -0.81 -0.66 -0.7 -0.64 -0.54 -0.6 -0.57 -0.58 -0.64 -0.83 -0.52 -0.45 -0.36 -0.38 -0.39 -0.4 -0.43 0.89 -0.35 -0.31 -0.28
EPS (rozwodnione) -0.41 -0.46 -0.53 -0.52 -1.58 -0.56 -0.93 -0.71 -0.81 -0.66 -0.7 -0.64 -0.54 -0.6 -0.57 -0.58 -0.64 -0.83 -0.52 -0.45 -0.36 -0.38 -0.39 -0.4 -0.43 0.87 -0.35 -0.31 -0.28
Ilośc akcji (mln) 17 17 17 17 23 23 18 23 23 24 27 28 32 33 37 41 41 41 46 52 60 62 62 62 62 62 62 54 62
Ważona ilośc akcji (mln) 17 17 17 17 23 23 18 23 23 24 27 28 32 33 37 41 41 41 46 52 60 62 62 62 62 64 62 54 62
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD